Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered ...
IND application filed for MP0712, the Company’s lead Radio-DARPin candidate targeting DLL3 and co-developed with Orano Med, with Phase 1 initiation expected before year end 2025 First patient images ...
Healing a wound without leaving a scar is something we could all do while in the womb. But unlocking this ability after birth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback